DALFAMPRIDINE

DALFAMPRIDINE was reported 71578 times

DALFAMPRIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAIT SPASTIC 123 0.3586
1 NEEDLE FATIGUE 87 0.1904
2 SOCIAL PROBLEM 687 0.1658
3 RELAPSING-REMITTING MULTIPLE SCLEROSIS 134 0.1551
4 JC VIRUS TEST POSITIVE 124 0.1473
5 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 224 0.1191
6 UPPER MOTOR NEURONE LESION 25 0.1136
7 PERONEAL NERVE PALSY 645 0.1134
8 T-LYMPHOCYTE COUNT INCREASED 21 0.1129
9 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 54 0.1116
10 CD8 LYMPHOCYTES DECREASED 22 0.1095
11 PROGRESSIVE MULTIPLE SCLEROSIS 116 0.1004
12 HAEMOGLOBIN URINE PRESENT 20 0.0985
13 CD4 LYMPHOCYTES INCREASED 22 0.0944
14 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 42 0.0929
15 WALKING AID USER 602 0.0912
16 THERAPY CESSATION 4511 0.0878
17 URINE LEUKOCYTE ESTERASE POSITIVE 61 0.0871
18 ORTHOSIS USER 24 0.0857
19 B-LYMPHOCYTE COUNT DECREASED 115 0.0844
20 URINE ANALYSIS ABNORMAL 232 0.0775
21 WHEELCHAIR USER 339 0.0762
22 MUSCLE SPASTICITY 883 0.0718
23 MULTIPLE SCLEROSIS RELAPSE 4788 0.0698
24 SARS-COV-2 ANTIBODY TEST NEGATIVE 33 0.0689
25 JC POLYOMAVIRUS TEST POSITIVE 78 0.0666
26 MULTIPLE SCLEROSIS 3136 0.0655
27 MULTIPLE SCLEROSIS PSEUDO RELAPSE 22 0.0649
28 NEUROGENIC BLADDER 134 0.0634
29 DECREASED VIBRATORY SENSE 20 0.0588
30 GAIT DISTURBANCE 10994 0.0574
31 BALANCE DISORDER 4909 0.0567
32 T-LYMPHOCYTE COUNT DECREASED 38 0.0557
33 VITAMIN B12 INCREASED 43 0.0540
34 CENTRAL NERVOUS SYSTEM LESION 726 0.0528
35 BLADDER DYSFUNCTION 51 0.0496
36 TRIGEMINAL NEURALGIA 198 0.0492
37 CULTURE URINE POSITIVE 68 0.0484
38 HYPERTONIC BLADDER 137 0.0474
39 MONOPARESIS 84 0.0464
40 DYSSTASIA 1349 0.0462
41 DYSGRAPHIA 304 0.0461
42 ACTIVITIES OF DAILY LIVING IMPAIRED 911 0.0460
43 DECREASED INTEREST 270 0.0457
44 CONTRAINDICATED DRUG ADMINISTERED 31 0.0443
45 BAND SENSATION 55 0.0433
46 URINARY TRACT INFECTION STAPHYLOCOCCAL 18 0.0422
47 MOBILITY DECREASED 3008 0.0418
48 FEAR OF FALLING 33 0.0404
49 URINARY TRACT INFECTION PSEUDOMONAL 24 0.0399
50 DYSMETRIA 24 0.0397
51 NITRITE URINE PRESENT 17 0.0388
52 LOSS OF CONTROL OF LEGS 143 0.0377
53 ESCHERICHIA URINARY TRACT INFECTION 158 0.0371
54 BLADDER DISORDER 368 0.0370
55 VITAMIN D INCREASED 22 0.0356
56 LYMPHOCYTE COUNT ABNORMAL 40 0.0355
57 TEMPERATURE INTOLERANCE 365 0.0353
58 CYSTITIS NONINFECTIVE 45 0.0335
59 MICTURITION URGENCY 381 0.0333
60 ABASIA 803 0.0325
61 HEAT EXHAUSTION 26 0.0323
62 RED BLOOD CELLS URINE POSITIVE 31 0.0321
63 BLADDER CATHETERISATION 31 0.0320
64 MAGNETIC RESONANCE IMAGING ABNORMAL 38 0.0318
65 THERAPEUTIC RESPONSE UNEXPECTED 1416 0.0315
66 HEMIANAESTHESIA 25 0.0313
67 CLUMSINESS 85 0.0311
68 PARAPARESIS 55 0.0308
69 FINE MOTOR SKILL DYSFUNCTION 89 0.0307
70 LIVING IN RESIDENTIAL INSTITUTION 56 0.0298
71 WHITE BLOOD CELLS URINE POSITIVE 55 0.0292
72 FUNCTIONAL GASTROINTESTINAL DISORDER 98 0.0283
73 IMPAIRED WORK ABILITY 600 0.0280
74 BLOOD IMMUNOGLOBULIN M DECREASED 28 0.0279
75 HYPOKINESIA 404 0.0278
76 LYMPHOCYTE PERCENTAGE DECREASED 37 0.0275
77 JOINT INSTABILITY 37 0.0264
78 URINARY TRACT INFECTION ENTEROCOCCAL 24 0.0257
79 POSTICTAL STATE 26 0.0250
80 MUSCLE FATIGUE 105 0.0248
81 MUSCULAR WEAKNESS 2796 0.0246
82 MOTOR DYSFUNCTION 250 0.0245
83 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1666 0.0234
84 URINARY TRACT INFECTION BACTERIAL 59 0.0233
85 BONE CONTUSION 21 0.0229
86 LABORATORY TEST ABNORMAL 668 0.0226
87 ATAXIA 265 0.0223
88 FALL 7361 0.0221
89 FLUSHING 2243 0.0220
90 URINARY TRACT INFECTION 3747 0.0219
91 BLADDER SPASM 41 0.0219
92 URGE INCONTINENCE 19 0.0218
93 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 72 0.0217
94 COORDINATION ABNORMAL 297 0.0213
95 HEMIPARESIS 356 0.0210
96 ESCHERICHIA TEST POSITIVE 25 0.0209
97 LYMPHOCYTE COUNT DECREASED 368 0.0208
98 GAIT INABILITY 695 0.0208
99 LIMB DISCOMFORT 621 0.0200
100 WHITE MATTER LESION 25 0.0198
101 URINARY INCONTINENCE 563 0.0190
102 MOVEMENT DISORDER 608 0.0189
103 CD4 LYMPHOCYTES DECREASED 40 0.0187
104 EXTENSOR PLANTAR RESPONSE 17 0.0184
105 JOINT LOCK 52 0.0183
106 MENOPAUSE 47 0.0182
107 MEMORY IMPAIRMENT 2447 0.0178
108 JC VIRUS INFECTION 28 0.0175
109 INCONTINENCE 182 0.0172
110 CYSTITIS 539 0.0169
111 ANKLE FRACTURE 261 0.0168
112 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 21 0.0168
113 CERVICAL SPINAL STENOSIS 29 0.0168
114 WALKING DISABILITY 35 0.0167
115 URINE ODOUR ABNORMAL 97 0.0165
116 WHITE BLOOD CELL DISORDER 44 0.0164
117 GENERAL SYMPTOM 123 0.0164
118 SKIN ABRASION 77 0.0163
119 ENERGY INCREASED 95 0.0161
120 FIBULA FRACTURE 46 0.0160
121 OPTIC NEURITIS 145 0.0159
122 URINARY HESITATION 38 0.0159
123 DRUG EFFECT VARIABLE 18 0.0159
124 INVASIVE DUCTAL BREAST CARCINOMA 43 0.0158
125 URINARY TRACT DISORDER 71 0.0157
126 BACTERIAL TEST POSITIVE 35 0.0157
127 TONGUE BITING 32 0.0155
128 FRACTURED SACRUM 19 0.0153
129 OPHTHALMOPLEGIA 24 0.0152
130 DIPLEGIA 30 0.0151
131 SENSORY DISTURBANCE 242 0.0151
132 IMMOBILE 65 0.0149
133 URINE KETONE BODY PRESENT 23 0.0146
134 HEAD TITUBATION 20 0.0145
135 SENSORY LOSS 117 0.0145
136 MUSCULOSKELETAL DISORDER 276 0.0145
137 CHEST INJURY 30 0.0145
138 BLADDER DISCOMFORT 18 0.0144
139 INTRADUCTAL PROLIFERATIVE BREAST LESION 18 0.0144
140 NEUTROPHIL PERCENTAGE INCREASED 18 0.0143
141 SEIZURE LIKE PHENOMENA 24 0.0141
142 MUSCLE TIGHTNESS 227 0.0140
143 INITIAL INSOMNIA 143 0.0139
144 SENSATION OF HEAVINESS 54 0.0139
145 CONTRAINDICATED PRODUCT PRESCRIBED 23 0.0137
146 VITAMIN D DECREASED 117 0.0137
147 HEAD INJURY 433 0.0137
148 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 650 0.0135
149 EXTRA DOSE ADMINISTERED 548 0.0135
150 POLLAKIURIA 564 0.0135
151 HYPOAESTHESIA 2007 0.0134
152 DECUBITUS ULCER 109 0.0134
153 COGNITIVE DISORDER 624 0.0133
154 BLOOD IMMUNOGLOBULIN G DECREASED 33 0.0133
155 ADVERSE DRUG REACTION 1188 0.0132
156 CALCULUS BLADDER 18 0.0132
157 MONOPLEGIA 57 0.0131
158 MEAN CELL HAEMOGLOBIN DECREASED 24 0.0131
159 DRUG DOSE OMISSION 2151 0.0130
160 TIBIA FRACTURE 61 0.0130
161 OPTIC ATROPHY 21 0.0129
162 PRODUCT DOSE OMISSION 839 0.0128
163 LACERATION 120 0.0127
164 DEMYELINATION 52 0.0127
165 URINE ABNORMALITY 57 0.0125
166 INSOMNIA 3311 0.0124
167 MEAN CELL VOLUME DECREASED 19 0.0123
168 LIGAMENT SPRAIN 121 0.0122
169 CONCUSSION 94 0.0121
170 WOUND INFECTION STAPHYLOCOCCAL 21 0.0121
171 IMPAIRED SELF-CARE 25 0.0121
172 ANAL INCONTINENCE 108 0.0120
173 NEURALGIA 291 0.0120
174 BEDRIDDEN 157 0.0119
175 MUSCULOSKELETAL STIFFNESS 1044 0.0119
176 NYSTAGMUS 63 0.0119
177 CLONUS 32 0.0117
178 CONDITION AGGRAVATED 3514 0.0115
179 INJECTION SITE ATROPHY 19 0.0115
180 PARAESTHESIA 1811 0.0115
181 INFLUENZA LIKE ILLNESS 946 0.0115
182 FRUSTRATION TOLERANCE DECREASED 91 0.0113
183 UROSEPSIS 103 0.0112
184 WEIGHT BEARING DIFFICULTY 30 0.0111
185 LOWER LIMB FRACTURE 212 0.0110
186 VITAMIN D DEFICIENCY 107 0.0110
187 INJECTION SITE SCAR 31 0.0109
188 MEAN CELL HAEMOGLOBIN INCREASED 18 0.0109
189 NOCTURIA 130 0.0107
190 FOOT FRACTURE 202 0.0106
191 DEPRESSED MOOD 557 0.0105
192 SEIZURE 1209 0.0105
193 EYE CONTUSION 22 0.0104
194 ATROPHY 20 0.0103
195 VERTIGO POSITIONAL 18 0.0103
196 LUMBAR SPINAL STENOSIS 30 0.0103
197 CATHETER PLACEMENT 19 0.0102
198 POSTURE ABNORMAL 33 0.0101
199 RED CELL DISTRIBUTION WIDTH INCREASED 42 0.0101
200 EYE MOVEMENT DISORDER 69 0.0101
201 LYMPHOPENIA 142 0.0100
202 UTERINE POLYP 18 0.0100
203 DIPLOPIA 259 0.0100
204 LIGAMENT RUPTURE 44 0.0100
205 SLOW SPEECH 24 0.0099
206 MICTURITION DISORDER 34 0.0098
207 BURNING SENSATION 684 0.0097
208 FACE INJURY 37 0.0097
209 HYPERREFLEXIA 33 0.0095
210 ASTHENIA 3471 0.0092
211 JOINT INJURY 195 0.0091
212 PATELLA FRACTURE 21 0.0090
213 PARESIS 20 0.0090
214 FACIAL PAIN 80 0.0090
215 WRIST FRACTURE 107 0.0089
216 HIP FRACTURE 286 0.0089
217 DYSPHEMIA 39 0.0089
218 SPINAL COLUMN STENOSIS 42 0.0089
219 MIDDLE INSOMNIA 166 0.0089
220 IMPAIRED DRIVING ABILITY 101 0.0089
221 CONVULSION 505 0.0088
222 FEELING JITTERY 168 0.0088
223 DRUG EFFECT DECREASED 473 0.0088
224 DEPRESSION 1997 0.0088
225 SLUGGISHNESS 89 0.0087
226 MUSCLE SPASMS 1596 0.0087
227 CEREBELLAR SYNDROME 19 0.0087
228 PERIPHERAL COLDNESS 119 0.0087
229 HEMIPLEGIA 72 0.0086
230 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 71 0.0086
231 PARALYSIS 123 0.0086
232 CEREBRAL ATROPHY 34 0.0085
233 DYSURIA 311 0.0084
234 DYSARTHRIA 315 0.0084
235 READING DISORDER 19 0.0083
236 RESTLESS LEGS SYNDROME 150 0.0082
237 INFECTION SUSCEPTIBILITY INCREASED 18 0.0082
238 URINARY RETENTION 273 0.0082
239 NECK INJURY 24 0.0082
240 BACK PAIN 1900 0.0082
241 RIB FRACTURE 167 0.0081
242 INTERVERTEBRAL DISC PROTRUSION 177 0.0081
243 UPPER LIMB FRACTURE 160 0.0080
244 DIZZINESS 4000 0.0080
245 MONOCYTE COUNT INCREASED 29 0.0080
246 ILL-DEFINED DISORDER 481 0.0079
247 HUMERUS FRACTURE 38 0.0079
248 LIMB INJURY 212 0.0078
249 KIDNEY INFECTION 152 0.0077
250 INTERVERTEBRAL DISC DISORDER 33 0.0077
251 FAECAL INCONTINENCE 37 0.0077
252 LYMPHOCYTE COUNT INCREASED 25 0.0077
253 VITAMIN B12 DECREASED 22 0.0076
254 OCULAR ICTERUS 33 0.0076
255 CRANIOCEREBRAL INJURY 23 0.0076
256 TREMOR 1255 0.0076
257 BLADDER PAIN 24 0.0076
258 MEDICATION RESIDUE PRESENT 36 0.0075
259 CONTUSION 725 0.0075
260 WHITE BLOOD CELL COUNT ABNORMAL 48 0.0075
261 LYMPHOEDEMA 52 0.0075
262 FEELING OF DESPAIR 35 0.0075
263 ADVERSE EVENT 691 0.0075
264 BLOOD THYROID STIMULATING HORMONE DECREASED 34 0.0075
265 MENISCUS INJURY 46 0.0075
266 NERVE COMPRESSION 69 0.0075
267 APHASIA 225 0.0074
268 PROTEIN URINE PRESENT 37 0.0074
269 VITAMIN B12 DEFICIENCY 30 0.0074
270 MEAN CELL VOLUME INCREASED 19 0.0074
271 CLAVICLE FRACTURE 28 0.0073
272 FRUSTRATION 26 0.0073
273 ELECTRIC SHOCK SENSATION 20 0.0071
274 FEELING HOT 438 0.0071
275 SNORING 27 0.0071
276 FATIGUE 5556 0.0071
277 HANGOVER 25 0.0071
278 BACK DISORDER 115 0.0071
279 MUSCLE STRAIN 61 0.0070
280 ADVERSE REACTION 93 0.0070
281 GRIP STRENGTH DECREASED 61 0.0069
282 HAND FRACTURE 49 0.0069
283 SPEECH DISORDER 362 0.0069
284 FOOD POISONING 37 0.0069
285 NEPHROLITHIASIS 316 0.0069
286 GASTROENTERITIS VIRAL 124 0.0069
287 MUSCLE CONTRACTIONS INVOLUNTARY 24 0.0068
288 INTERVERTEBRAL DISC DEGENERATION 63 0.0068
289 THYROID MASS 26 0.0068
290 VERTIGO 412 0.0068
291 FORMICATION 47 0.0067
292 CONTRAINDICATED PRODUCT ADMINISTERED 201 0.0066
293 ONYCHOMYCOSIS 29 0.0066
294 MUSCLE TWITCHING 152 0.0066
295 BLOOD CHLORIDE DECREASED 17 0.0066
296 DYSAESTHESIA 20 0.0065
297 HYPERSOMNIA 187 0.0065
298 CHROMATURIA 147 0.0065
299 CONSTIPATION 1420 0.0065
300 GRAND MAL CONVULSION 60 0.0065
301 ROTATOR CUFF SYNDROME 83 0.0065
302 JOINT DISLOCATION 68 0.0064
303 FEELING COLD 177 0.0064
304 BACK INJURY 69 0.0063
305 DRUG INEFFECTIVE 8325 0.0063
306 PRESCRIBED UNDERDOSE 126 0.0063
307 MENTAL IMPAIRMENT 153 0.0063
308 HERPES ZOSTER 362 0.0063
309 PAIN IN EXTREMITY 1851 0.0063
310 LUNG CANCER METASTATIC 18 0.0062
311 PARAPLEGIA 18 0.0062
312 HYPERVENTILATION 36 0.0062
313 REHABILITATION THERAPY 24 0.0062
314 SKIN LACERATION 67 0.0062
315 WHITE BLOOD CELL COUNT DECREASED 667 0.0061
316 SCOLIOSIS 38 0.0061
317 FACIAL BONES FRACTURE 22 0.0061
318 STATUS EPILEPTICUS 69 0.0061
319 GENERALISED TONIC-CLONIC SEIZURE 101 0.0061
320 HOT FLUSH 455 0.0060
321 SPINAL OSTEOARTHRITIS 53 0.0060
322 LYME DISEASE 20 0.0060
323 YELLOW SKIN 28 0.0060
324 VISUAL IMPAIRMENT 740 0.0060
325 SCIATICA 95 0.0060
326 ABDOMINAL DISCOMFORT 995 0.0059
327 FEELING ABNORMAL 1421 0.0059
328 SPINAL DISORDER 56 0.0059
329 CORONAVIRUS INFECTION 39 0.0059
330 FOOT OPERATION 29 0.0059
331 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17 0.0058
332 NASAL DISCOMFORT 46 0.0058
333 FEELING DRUNK 43 0.0058
334 ACCIDENT 69 0.0058
335 NEUTROPHIL COUNT INCREASED 59 0.0058
336 BLOOD CREATININE DECREASED 18 0.0057
337 AMNESIA 371 0.0057
338 METABOLIC ENCEPHALOPATHY 17 0.0057
339 PELVIC FRACTURE 44 0.0056
340 FEELING OF BODY TEMPERATURE CHANGE 33 0.0056
341 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 28 0.0056
342 MAJOR DEPRESSION 41 0.0056
343 ROAD TRAFFIC ACCIDENT 232 0.0055
344 SPONDYLITIS 20 0.0055
345 FUNGAL SKIN INFECTION 22 0.0054
346 MUSCLE DISORDER 44 0.0054
347 GASTROINTESTINAL MOTILITY DISORDER 29 0.0054
348 CARPAL TUNNEL SYNDROME 75 0.0053
349 INTENTIONAL UNDERDOSE 39 0.0053
350 VAGINAL INFECTION 25 0.0053
351 SINUS DISORDER 105 0.0053
352 SPINAL OPERATION 65 0.0053
353 CEREBRAL DISORDER 39 0.0053
354 FEMORAL NECK FRACTURE 27 0.0053
355 CREATININE RENAL CLEARANCE DECREASED 21 0.0052
356 HEADACHE 3274 0.0052
357 HYPOTONIA 52 0.0052
358 INFLUENZA 577 0.0052
359 ARTHROPOD BITE 38 0.0051
360 INCOHERENT 33 0.0051
361 PROSTATOMEGALY 20 0.0051
362 SPINAL STENOSIS 21 0.0051
363 SEASONAL ALLERGY 72 0.0051
364 APATHY 74 0.0051
365 POOR QUALITY SLEEP 108 0.0050
366 DEFAECATION URGENCY 35 0.0050
367 SKIN WARM 29 0.0050
368 NASOPHARYNGITIS 914 0.0050
369 BLOOD URINE PRESENT 93 0.0049
370 THERAPEUTIC RESPONSE CHANGED 31 0.0049
371 HAEMATOCRIT DECREASED 97 0.0049
372 NECK PAIN 270 0.0048
373 BRUXISM 26 0.0048
374 HEPATIC ENZYME ABNORMAL 24 0.0048
375 DECREASED IMMUNE RESPONSIVENESS 47 0.0048
376 HYPOAESTHESIA ORAL 72 0.0048
377 PARTIAL SEIZURES 25 0.0048
378 IMMUNOSUPPRESSION 42 0.0048
379 SENSITIVITY TO WEATHER CHANGE 25 0.0047
380 BRADYKINESIA 28 0.0047
381 INTRACRANIAL ANEURYSM 19 0.0047
382 THINKING ABNORMAL 88 0.0047
383 HYPERTONIA 27 0.0047
384 ALOPECIA 923 0.0047
385 VITREOUS FLOATERS 46 0.0047
386 INJECTION SITE REACTION 321 0.0047
387 THERAPY INTERRUPTED 333 0.0047
388 COVID-19 817 0.0047
389 TEARFULNESS 20 0.0046
390 FULL BLOOD COUNT ABNORMAL 49 0.0046
391 DISORIENTATION 183 0.0046
392 DYSPEPSIA 454 0.0046
393 MYOCLONUS 55 0.0046
394 SLEEP DISORDER 325 0.0046
395 VEIN DISORDER 23 0.0046
396 BRADYPHRENIA 30 0.0046
397 VULVOVAGINAL MYCOTIC INFECTION 18 0.0046
398 TOOTH INFECTION 60 0.0045
399 DRY THROAT 46 0.0045
400 DISTURBANCE IN ATTENTION 244 0.0045
401 MIGRAINE 428 0.0045
402 IMMUNE SYSTEM DISORDER 59 0.0045
403 AFFECT LABILITY 43 0.0045
404 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 245 0.0045
405 JOINT STIFFNESS 117 0.0045
406 INCREASED TENDENCY TO BRUISE 41 0.0045
407 SCRATCH 47 0.0045
408 RENAL PAIN 47 0.0044
409 FOOT DEFORMITY 49 0.0044
410 MALAISE 1937 0.0044
411 LOW DENSITY LIPOPROTEIN INCREASED 34 0.0044
412 UTERINE LEIOMYOMA 32 0.0044
413 DYSKINESIA 177 0.0044
414 INJECTION SITE MASS 161 0.0043
415 DYSPHAGIA 412 0.0043
416 NERVE INJURY 48 0.0043
417 CONFUSIONAL STATE 696 0.0043
418 PHOTOPSIA 27 0.0043
419 PERIPHERAL VASCULAR DISORDER 22 0.0043
420 TENSION 26 0.0043
421 SPINAL PAIN 50 0.0043
422 CHILLS 497 0.0042
423 GASTROINTESTINAL INFECTION 38 0.0042
424 ERECTILE DYSFUNCTION 108 0.0042
425 GASTRIC DISORDER 144 0.0042
426 CARDIAC FLUTTER 27 0.0042
427 HORDEOLUM 18 0.0042
428 PERIPHERAL SWELLING 639 0.0041
429 MUSCULOSKELETAL CHEST PAIN 64 0.0041
430 ESCHERICHIA INFECTION 34 0.0041
431 HEAD DISCOMFORT 73 0.0041
432 BLINDNESS UNILATERAL 58 0.0041
433 MELANOCYTIC NAEVUS 18 0.0041
434 BLOOD COUNT ABNORMAL 62 0.0041
435 MASS 57 0.0041
436 KNEE OPERATION 40 0.0041
437 BLOOD TEST ABNORMAL 57 0.0041
438 GENERALISED ERYTHEMA 23 0.0040
439 SINUS HEADACHE 24 0.0040
440 PYELONEPHRITIS 35 0.0040
441 BASAL CELL CARCINOMA 63 0.0040
442 MALIGNANT MELANOMA 54 0.0040
443 DIZZINESS POSTURAL 39 0.0040
444 ANEURYSM 20 0.0040
445 THROAT IRRITATION 180 0.0040
446 DEAFNESS UNILATERAL 22 0.0040
447 VISION BLURRED 548 0.0040
448 BLEPHAROSPASM 25 0.0040
449 CRYING 144 0.0040
450 PARAESTHESIA ORAL 57 0.0039
451 MUSCLE ATROPHY 50 0.0039
452 EAR DISORDER 18 0.0039
453 TOOTH FRACTURE 43 0.0039
454 TINNITUS 179 0.0039
455 SLEEP APNOEA SYNDROME 74 0.0039
456 FACIAL PARALYSIS 33 0.0039
457 CELLULITIS 195 0.0039
458 ROSACEA 18 0.0039
459 EYE DISORDER 127 0.0039
460 HYSTERECTOMY 33 0.0038
461 DENTAL CARIES 42 0.0038
462 NIGHT SWEATS 122 0.0038
463 SARS-COV-2 TEST POSITIVE 50 0.0038
464 ERYSIPELAS 19 0.0038
465 IRON DEFICIENCY 17 0.0038
466 BIPOLAR DISORDER 41 0.0038
467 DRUG EFFECT DELAYED 17 0.0037
468 MACULAR OEDEMA 21 0.0037
469 DRY MOUTH 304 0.0037
470 DISABILITY 74 0.0037
471 OVERWEIGHT 20 0.0037
472 MUSCULOSKELETAL DISCOMFORT 64 0.0037
473 CHOKING 72 0.0037
474 HYPERLIPIDAEMIA 44 0.0037
475 FEMUR FRACTURE 114 0.0037
476 CHOLECYSTECTOMY 42 0.0037
477 NEUROLOGICAL SYMPTOM 21 0.0037
478 COVID-19 PNEUMONIA 43 0.0036
479 CHOLELITHIASIS 119 0.0036
480 BURSITIS 44 0.0036
481 BLOOD POTASSIUM DECREASED 109 0.0036
482 CLOSTRIDIUM DIFFICILE INFECTION 79 0.0036
483 OROPHARYNGEAL PAIN 335 0.0036
484 EAR DISCOMFORT 37 0.0036
485 HYPERTRANSAMINASAEMIA 25 0.0036
486 HEPATIC ENZYME INCREASED 244 0.0036
487 MOOD SWINGS 114 0.0036
488 FAECES SOFT 26 0.0036
489 THYROID DISORDER 55 0.0036
490 NAUSEA 2823 0.0036
491 WOUND INFECTION 39 0.0036
492 VULVOVAGINAL PRURITUS 18 0.0036
493 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
494 ENCEPHALOPATHY 87 0.0035
495 MENTAL STATUS CHANGES 98 0.0035
496 PAIN 2166 0.0035
497 BLINDNESS TRANSIENT 26 0.0035
498 BLOOD SODIUM DECREASED 66 0.0035
499 GLOMERULAR FILTRATION RATE DECREASED 43 0.0035
500 SEXUAL DYSFUNCTION 41 0.0035
501 ABDOMINAL PAIN UPPER 719 0.0035
502 GALLBLADDER DISORDER 62 0.0035
503 WOUND 97 0.0035
504 GASTROINTESTINAL DISORDER 310 0.0035
505 VISUAL FIELD DEFECT 25 0.0035
506 PHARYNGEAL OEDEMA 53 0.0034
507 LOSS OF CONSCIOUSNESS 440 0.0034
508 POST-TRAUMATIC STRESS DISORDER 23 0.0034
509 PRURITUS GENERALISED 74 0.0034
510 STAPHYLOCOCCAL INFECTION 112 0.0034
511 INJECTION SITE INDURATION 44 0.0034
512 OBESITY 54 0.0034
513 NERVOUSNESS 177 0.0034
514 MUSCULOSKELETAL PAIN 177 0.0034
515 BLOOD THYROID STIMULATING HORMONE INCREASED 31 0.0034
516 ARTHROPATHY 187 0.0034
517 DRUG EFFECT INCOMPLETE 122 0.0034
518 LIVER FUNCTION TEST INCREASED 72 0.0034
519 PETIT MAL EPILEPSY 17 0.0033
520 ANXIETY 944 0.0033
521 SQUAMOUS CELL CARCINOMA OF SKIN 20 0.0033
522 FLANK PAIN 31 0.0033
523 GROIN PAIN 29 0.0033
524 EXERCISE TOLERANCE DECREASED 19 0.0033
525 HERPES VIRUS INFECTION 19 0.0033
526 GLYCOSYLATED HAEMOGLOBIN INCREASED 83 0.0033
527 BODY TEMPERATURE INCREASED 67 0.0033
528 ORAL HERPES 64 0.0033
529 PRURITUS 1259 0.0033
530 FEAR 88 0.0033
531 VISUAL ACUITY REDUCED 108 0.0032
532 SOMNOLENCE 653 0.0032
533 CONCOMITANT DISEASE AGGRAVATED 20 0.0032
534 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
535 PERSONALITY CHANGE 30 0.0032
536 APHONIA 45 0.0032
537 LOCAL SWELLING 56 0.0032
538 BLOOD IRON DECREASED 38 0.0032
539 NO THERAPEUTIC RESPONSE 39 0.0032
540 RED BLOOD CELL COUNT DECREASED 91 0.0032
541 AFFECTIVE DISORDER 25 0.0032
542 COMPRESSION FRACTURE 17 0.0032
543 SINUSITIS 325 0.0032
544 HYPERAESTHESIA 26 0.0032
545 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
546 SCAR 54 0.0032
547 PHOTOPHOBIA 59 0.0031
548 HIP ARTHROPLASTY 48 0.0031
549 PSYCHOMOTOR HYPERACTIVITY 52 0.0031
550 RASH PRURITIC 169 0.0031
551 JAW DISORDER 17 0.0031
552 THERMAL BURN 22 0.0031
553 POOR VENOUS ACCESS 32 0.0031
554 DRUG SPECIFIC ANTIBODY PRESENT 20 0.0031
555 COLD SWEAT 54 0.0031
556 RHINORRHOEA 198 0.0031
557 MULTIPLE ALLERGIES 24 0.0031
558 BRONCHITIS 226 0.0031
559 ONYCHOCLASIS 21 0.0030
560 HEART RATE ABNORMAL 17 0.0030
561 VIRAL INFECTION 101 0.0030
562 EAR PAIN 59 0.0030
563 HAIR GROWTH ABNORMAL 21 0.0030
564 CATARACT OPERATION 18 0.0030
565 SKIN INFECTION 34 0.0030
566 MENSTRUAL DISORDER 25 0.0030
567 PREGNANCY 60 0.0030
568 INJECTION SITE ERYTHEMA 371 0.0030
569 OSTEOPOROSIS 123 0.0030
570 CYST 37 0.0030
571 ABNORMAL DREAMS 82 0.0030
572 SINUS CONGESTION 40 0.0030
573 INGUINAL HERNIA 18 0.0030
574 SPINAL FRACTURE 59 0.0029
575 FUNGAL INFECTION 98 0.0029
576 HEART RATE DECREASED 103 0.0029
577 EUPHORIC MOOD 30 0.0029
578 PANIC REACTION 21 0.0029
579 RETCHING 62 0.0029
580 LETHARGY 167 0.0029
581 OVARIAN CYST 29 0.0029
582 UPPER RESPIRATORY TRACT INFECTION 134 0.0029
583 BRAIN INJURY 29 0.0029
584 DECREASED ACTIVITY 31 0.0029
585 SKIN DISCOLOURATION 132 0.0029
586 NASAL DRYNESS 18 0.0029
587 HYPERSENSITIVITY 533 0.0029
588 UTERINE CANCER 23 0.0029
589 SEPSIS 318 0.0028
590 SKIN MASS 19 0.0028
591 MENINGITIS 19 0.0028
592 PNEUMONIA ASPIRATION 71 0.0028
593 BREAST MASS 19 0.0028
594 BLOOD PRESSURE ABNORMAL 56 0.0028
595 LOCALISED INFECTION 68 0.0028
596 ARTHRITIS 221 0.0028
597 ULCER HAEMORRHAGE 19 0.0028
598 GENERAL PHYSICAL CONDITION ABNORMAL 19 0.0028
599 UNRESPONSIVE TO STIMULI 72 0.0028
600 MOOD ALTERED 76 0.0028
601 PAROSMIA 21 0.0028
602 BLOOD MAGNESIUM DECREASED 24 0.0028
603 EAR INFECTION 74 0.0028
604 ANGER 94 0.0028
605 SKIN REACTION 39 0.0028
606 BLOOD DISORDER 22 0.0027
607 GENERAL PHYSICAL HEALTH DETERIORATION 315 0.0027
608 OSTEOARTHRITIS 115 0.0027
609 IRON DEFICIENCY ANAEMIA 25 0.0027
610 TOOTHACHE 49 0.0027
611 BLOOD CHOLESTEROL INCREASED 126 0.0027
612 HAEMATOMA 70 0.0027
613 DYSPHONIA 158 0.0027
614 BLOOD ALKALINE PHOSPHATASE INCREASED 67 0.0027
615 URTICARIA 451 0.0027
616 PALPITATIONS 314 0.0027
617 HICCUPS 22 0.0027
618 CANDIDA INFECTION 45 0.0027
619 PANIC ATTACK 97 0.0027
620 WEIGHT DECREASED 741 0.0027
621 HAEMOGLOBIN ABNORMAL 17 0.0026
622 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 476 0.0026
623 EOSINOPHIL COUNT INCREASED 22 0.0026
624 DIARRHOEA 1687 0.0026
625 BLINDNESS 106 0.0026
626 SURGERY 152 0.0026
627 MUSCLE RIGIDITY 31 0.0026
628 PHARYNGITIS STREPTOCOCCAL 28 0.0026
629 HYPERHIDROSIS 333 0.0026
630 NIGHTMARE 89 0.0026
631 INFECTION 372 0.0026
632 THERAPEUTIC PRODUCT EFFECT DECREASED 115 0.0026
633 TOOTH ABSCESS 26 0.0026
634 SQUAMOUS CELL CARCINOMA 24 0.0025
635 IMMUNODEFICIENCY 38 0.0025
636 BLOOD GLUCOSE ABNORMAL 47 0.0025
637 GLAUCOMA 49 0.0025
638 HAIR TEXTURE ABNORMAL 34 0.0025
639 FLATULENCE 144 0.0025
640 DEHYDRATION 338 0.0025
641 FURUNCLE 20 0.0025
642 KNEE ARTHROPLASTY 53 0.0025
643 FEEDING DISORDER 51 0.0025
644 RASH ERYTHEMATOUS 120 0.0025
645 TENDERNESS 26 0.0025
646 BLOOD PRESSURE INCREASED 378 0.0025
647 ASPIRATION 27 0.0025
648 HEART RATE INCREASED 244 0.0025
649 BLOOD UREA INCREASED 41 0.0024
650 HYPERTENSION 516 0.0024
651 EXOSTOSIS 22 0.0024
652 BLOOD CALCIUM DECREASED 27 0.0024
653 INJECTION SITE DISCOLOURATION 30 0.0024
654 BRAIN NEOPLASM 22 0.0024
655 DISCOMFORT 146 0.0024
656 GASTROOESOPHAGEAL REFLUX DISEASE 192 0.0024
657 PULMONARY THROMBOSIS 26 0.0024
658 HYPOTHYROIDISM 76 0.0024
659 FRACTURE 45 0.0024
660 OSTEOPENIA 36 0.0024
661 DEMENTIA 66 0.0024
662 AUTOIMMUNE DISORDER 23 0.0024
663 ERYTHEMA 485 0.0024
664 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
665 BOWEL MOVEMENT IRREGULARITY 18 0.0023
666 DRUG INTOLERANCE 226 0.0023
667 CORONARY ARTERY OCCLUSION 32 0.0023
668 ERUCTATION 45 0.0023
669 EPILEPSY 71 0.0023
670 OSTEOMYELITIS 42 0.0023
671 RENAL DISORDER 108 0.0023
672 IMPAIRED HEALING 76 0.0023
673 NASAL CONGESTION 136 0.0023
674 NEUROPATHY PERIPHERAL 220 0.0023
675 MYALGIA 392 0.0023
676 JOINT SWELLING 277 0.0023
677 ELECTROCARDIOGRAM ABNORMAL 18 0.0023
678 THROAT TIGHTNESS 62 0.0023
679 NAIL DISORDER 20 0.0023
680 ATELECTASIS 22 0.0023
681 HYPOACUSIS 98 0.0023
682 ARTHRALGIA 946 0.0023
683 HALLUCINATION, VISUAL 48 0.0023
684 WEIGHT INCREASED 509 0.0023
685 GASTROINTESTINAL PAIN 25 0.0023
686 RENAL CYST 18 0.0023
687 PRESYNCOPE 55 0.0023
688 PAIN IN JAW 64 0.0023
689 BACTERIAL INFECTION 42 0.0022
690 CATARACT 134 0.0022
691 INJECTION SITE BRUISING 179 0.0022
692 VOMITING 1048 0.0022
693 SYNCOPE 223 0.0022
694 COUGH 624 0.0022
695 EYE INFECTION 25 0.0022
696 ABDOMINAL DISTENSION 231 0.0022
697 HEART RATE IRREGULAR 50 0.0022
698 LEUKOCYTOSIS 40 0.0022
699 TOOTH DISORDER 49 0.0022
700 WEIGHT FLUCTUATION 23 0.0022
701 SPINAL COMPRESSION FRACTURE 18 0.0022
702 SWOLLEN TONGUE 68 0.0022
703 INJECTION SITE URTICARIA 53 0.0022
704 COLON CANCER 32 0.0021
705 SENSATION OF FOREIGN BODY 18 0.0021
706 IRRITABILITY 128 0.0021
707 FLUID RETENTION 108 0.0021
708 PHOTOSENSITIVITY REACTION 35 0.0021
709 PNEUMONIA 685 0.0021
710 RASH 910 0.0021
711 POST PROCEDURAL COMPLICATION 40 0.0021
712 BREAST CANCER 194 0.0021
713 HALLUCINATION 156 0.0021
714 ALANINE AMINOTRANSFERASE INCREASED 127 0.0021
715 RETINAL DETACHMENT 19 0.0021
716 BLOOD PRESSURE DECREASED 137 0.0021
717 IRRITABLE BOWEL SYNDROME 44 0.0021
718 SKIN ULCER 53 0.0020
719 PRODUCT DOSE OMISSION ISSUE 600 0.0020
720 BODY TEMPERATURE DECREASED 20 0.0020
721 PYREXIA 703 0.0020
722 PARANOIA 35 0.0020
723 ACCIDENTAL OVERDOSE 74 0.0020
724 EATING DISORDER 43 0.0020
725 OEDEMA PERIPHERAL 246 0.0020
726 SCAB 23 0.0020
727 EYE PAIN 113 0.0020
728 CHEST DISCOMFORT 205 0.0020
729 DIABETES MELLITUS 152 0.0020
730 VAGINAL DISCHARGE 20 0.0020
731 GOUT 35 0.0019
732 RESTLESSNESS 71 0.0019
733 BLOOD CALCIUM INCREASED 17 0.0019
734 HIATUS HERNIA 25 0.0019
735 APPENDICITIS 18 0.0019
736 LIVER FUNCTION TEST ABNORMAL 56 0.0019
737 BRADYCARDIA 102 0.0019
738 LIP SWELLING 64 0.0019
739 ORAL PAIN 43 0.0019
740 RASH PAPULAR 43 0.0019
741 HERNIA 37 0.0019
742 SWELLING 179 0.0019
743 SKIN CANCER 41 0.0019
744 UNEVALUABLE EVENT 143 0.0019
745 DRUG EFFECT LESS THAN EXPECTED 28 0.0019
746 THROMBOSIS 152 0.0019
747 HYPOPHAGIA 48 0.0019
748 HYPOTHERMIA 19 0.0019
749 DECREASED APPETITE 434 0.0019
750 CEREBROVASCULAR ACCIDENT 316 0.0019
751 AGITATION 137 0.0019
752 RASH GENERALISED 48 0.0019
753 CHEST PAIN 342 0.0018
754 DERMATITIS CONTACT 21 0.0018
755 PLATELET COUNT INCREASED 24 0.0018
756 TRANSIENT ISCHAEMIC ATTACK 62 0.0018
757 RASH MACULAR 64 0.0018
758 THERAPY CHANGE 18 0.0018
759 DEVICE RELATED INFECTION 28 0.0018
760 DEEP VEIN THROMBOSIS 117 0.0018
761 PULMONARY EMBOLISM 171 0.0018
762 SKIN DISORDER 60 0.0018
763 DEAFNESS 47 0.0018
764 HYPERTHYROIDISM 26 0.0018
765 JOINT RANGE OF MOTION DECREASED 24 0.0018
766 GASTRITIS 47 0.0018
767 BREAST PAIN 19 0.0018
768 LIVER DISORDER 79 0.0018
769 BLISTER 100 0.0018
770 DRUG INTERACTION 282 0.0018
771 PHARYNGITIS 22 0.0018
772 SUICIDAL IDEATION 162 0.0018
773 NERVOUS SYSTEM DISORDER 55 0.0018
774 ULCER 28 0.0018
775 EMOTIONAL DISORDER 54 0.0017
776 ORAL CANDIDIASIS 23 0.0017
777 PULMONARY MASS 26 0.0017
778 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
779 FIBROMYALGIA 42 0.0017
780 PETECHIAE 18 0.0017
781 HOSPICE CARE 17 0.0017
782 DISEASE PROGRESSION 202 0.0017
783 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 89 0.0017
784 PANCREATITIS 90 0.0017
785 TENDON RUPTURE 21 0.0017
786 TREATMENT NONCOMPLIANCE 93 0.0017
787 ABDOMINAL PAIN 391 0.0017
788 SUBDURAL HAEMATOMA 24 0.0017
789 ANHEDONIA 44 0.0017
790 BRAIN FOG 26 0.0017
791 MEDICATION ERROR 92 0.0017
792 DELIRIUM 57 0.0016
793 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
794 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
795 DELUSION 25 0.0016
796 TOOTH EXTRACTION 20 0.0016
797 SNEEZING 36 0.0016
798 BONE DISORDER 29 0.0016
799 INCORRECT DOSE ADMINISTERED 360 0.0016
800 SKIN LESION 43 0.0016
801 CONJUNCTIVITIS 29 0.0016
802 MENTAL DISORDER 68 0.0016
803 HEPATIC STEATOSIS 29 0.0016
804 INJECTION SITE PRURITUS 104 0.0016
805 ORTHOSTATIC HYPOTENSION 27 0.0015
806 WITHDRAWAL SYNDROME 65 0.0015
807 INFLAMMATION 79 0.0015
808 OEDEMA 83 0.0015
809 COLITIS 58 0.0015
810 GASTRIC ULCER 29 0.0015
811 INJECTION SITE PAIN 468 0.0015
812 MALNUTRITION 17 0.0015
813 PULMONARY CONGESTION 20 0.0015
814 CHOLECYSTITIS 18 0.0015
815 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
816 BLOOD CREATININE INCREASED 98 0.0015
817 INJECTION SITE RASH 46 0.0015
818 RESPIRATORY TRACT INFECTION 39 0.0015
819 THYROID CANCER 18 0.0015
820 QUALITY OF LIFE DECREASED 20 0.0015
821 DYSGEUSIA 110 0.0015
822 DIVERTICULITIS 41 0.0015
823 NEOPLASM 17 0.0015
824 MENINGIOMA 23 0.0015
825 RESPIRATORY DISORDER 44 0.0015
826 INCREASED APPETITE 28 0.0015
827 RENAL IMPAIRMENT 123 0.0015
828 LUNG NEOPLASM MALIGNANT 60 0.0015
829 EYE SWELLING 54 0.0015
830 PNEUMOTHORAX 23 0.0014
831 INFUSION RELATED REACTION 96 0.0014
832 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
833 ABSCESS 23 0.0014
834 ANGINA PECTORIS 41 0.0014
835 SKIN HAEMORRHAGE 21 0.0014
836 BLOOD POTASSIUM INCREASED 23 0.0014
837 SWELLING FACE 92 0.0014
838 SKIN BURNING SENSATION 101 0.0014
839 FREQUENT BOWEL MOVEMENTS 38 0.0014
840 GINGIVAL BLEEDING 19 0.0014
841 PSYCHOTIC DISORDER 41 0.0014
842 EXPIRED PRODUCT ADMINISTERED 46 0.0014
843 DRY EYE 69 0.0014
844 ORAL DISCOMFORT 19 0.0014
845 OFF LABEL USE 1196 0.0014
846 LEUKOPENIA 68 0.0014
847 PRODUCT SUBSTITUTION ISSUE 78 0.0014
848 ACUTE RESPIRATORY FAILURE 26 0.0014
849 MYOCARDIAL INFARCTION 235 0.0013
850 THIRST 24 0.0013
851 PRODUCTIVE COUGH 64 0.0013
852 FULL BLOOD COUNT DECREASED 27 0.0013
853 INJECTION SITE IRRITATION 17 0.0013
854 BLOOD BILIRUBIN INCREASED 36 0.0013
855 INTESTINAL OBSTRUCTION 50 0.0013
856 CARDIAC DISORDER 123 0.0013
857 DYSPNOEA 742 0.0013
858 INJECTION SITE HAEMATOMA 19 0.0013
859 HEPATOTOXICITY 29 0.0013
860 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
861 HUNGER 18 0.0013
862 TENDONITIS 20 0.0013
863 FAECES DISCOLOURED 28 0.0013
864 AGEUSIA 32 0.0013
865 NEOPLASM MALIGNANT 85 0.0013
866 ATRIAL FIBRILLATION 124 0.0013
867 LYMPHADENOPATHY 45 0.0013
868 PROCEDURAL PAIN 35 0.0013
869 DEATH 1080 0.0013
870 BONE PAIN 73 0.0012
871 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
872 BREAST CANCER FEMALE 33 0.0012
873 ILLNESS 127 0.0012
874 HAEMORRHOIDS 24 0.0012
875 HAEMATURIA 42 0.0012
876 BLOOD PRESSURE FLUCTUATION 29 0.0012
877 THERAPY NON-RESPONDER 54 0.0012
878 LACRIMATION INCREASED 36 0.0012
879 ABDOMINAL PAIN LOWER 30 0.0012
880 ANOSMIA 17 0.0012
881 HYPOTENSION 235 0.0012
882 HAEMOGLOBIN DECREASED 120 0.0012
883 GLOSSODYNIA 26 0.0012
884 INJECTION SITE SWELLING 88 0.0011
885 NEUROTOXICITY 20 0.0011
886 TACHYCARDIA 101 0.0011
887 HALLUCINATION, AUDITORY 18 0.0011
888 MENORRHAGIA 22 0.0011
889 PRODUCT USE IN UNAPPROVED INDICATION 277 0.0011
890 INJURY 78 0.0011
891 UNDERDOSE 81 0.0011
892 BLOOD GLUCOSE INCREASED 208 0.0011
893 TYPE 2 DIABETES MELLITUS 37 0.0011
894 LUNG INFECTION 17 0.0011
895 CEREBRAL HAEMORRHAGE 39 0.0011
896 RESPIRATORY ARREST 30 0.0011
897 DRY SKIN 145 0.0011
898 EPISTAXIS 80 0.0011
899 ARRHYTHMIA 50 0.0011
900 HEPATITIS 27 0.0011
901 ACNE 79 0.0010
902 INJECTION SITE WARMTH 21 0.0010
903 NO ADVERSE EVENT 184 0.0010
904 TOOTH LOSS 21 0.0010
905 PAIN OF SKIN 27 0.0010
906 SEPTIC SHOCK 43 0.0010
907 BLOOD GLUCOSE DECREASED 47 0.0010
908 HOSPITALISATION 149 0.0010
909 COMA 46 0.0010
910 SKIN IRRITATION 43 0.0009
911 MENSTRUATION IRREGULAR 25 0.0009
912 ASTHMA 105 0.0009
913 CARDIAC FAILURE CONGESTIVE 74 0.0009
914 CORONARY ARTERY DISEASE 27 0.0009
915 HYPOKALAEMIA 41 0.0009
916 ECZEMA 46 0.0009
917 SEDATION 23 0.0009
918 INJECTION SITE HAEMORRHAGE 70 0.0009
919 STOMATITIS 53 0.0009
920 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
921 CARDIOVASCULAR DISORDER 22 0.0009
922 OCULAR HYPERAEMIA 41 0.0009
923 CEREBRAL INFARCTION 21 0.0009
924 THERAPEUTIC RESPONSE DECREASED 52 0.0009
925 ANAEMIA 163 0.0009
926 WRONG TECHNIQUE IN DRUG USAGE PROCESS 31 0.0009
927 CARDIAC ARREST 70 0.0008
928 ACUTE MYOCARDIAL INFARCTION 25 0.0008
929 TREATMENT FAILURE 70 0.0008
930 ABNORMAL BEHAVIOUR 33 0.0008
931 SKIN EXFOLIATION 70 0.0008
932 RESPIRATORY FAILURE 59 0.0008
933 AGGRESSION 40 0.0008
934 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
935 RENAL FAILURE 106 0.0008
936 DRUG ADMINISTRATION ERROR 24 0.0008
937 EMOTIONAL DISTRESS 94 0.0008
938 EYE PRURITUS 26 0.0008
939 PALLOR 21 0.0008
940 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
941 HAEMORRHAGE 78 0.0007
942 HAEMATOCHEZIA 40 0.0007
943 NEUTROPHIL COUNT DECREASED 29 0.0007
944 WHEEZING 42 0.0007
945 LIVER INJURY 17 0.0007
946 PANCREATIC CARCINOMA 20 0.0007
947 PULMONARY OEDEMA 30 0.0007
948 JAUNDICE 18 0.0007
949 C-REACTIVE PROTEIN INCREASED 24 0.0007
950 HYPERGLYCAEMIA 24 0.0007
951 INTENTIONAL PRODUCT MISUSE 56 0.0006
952 VAGINAL HAEMORRHAGE 27 0.0006
953 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
954 RENAL FAILURE ACUTE 26 0.0006
955 LUNG DISORDER 30 0.0006
956 INTENTIONAL DOSE OMISSION 17 0.0006
957 PLATELET COUNT DECREASED 63 0.0006
958 CARDIAC FAILURE 47 0.0006
959 RECTAL HAEMORRHAGE 25 0.0006
960 OSTEONECROSIS 19 0.0006
961 ABORTION SPONTANEOUS 23 0.0006
962 CARDIO-RESPIRATORY ARREST 24 0.0006
963 EYE IRRITATION 33 0.0006
964 HYPOXIA 20 0.0006
965 MATERNAL EXPOSURE DURING PREGNANCY 49 0.0005
966 PRODUCT USE ISSUE 102 0.0005
967 HYPOGLYCAEMIA 25 0.0005
968 ANAPHYLACTIC REACTION 28 0.0005
969 RHABDOMYOLYSIS 21 0.0005
970 PROSTATE CANCER 40 0.0005
971 HYPONATRAEMIA 28 0.0005
972 BLADDER CANCER 29 0.0005
973 SUICIDE ATTEMPT 29 0.0005
974 COLITIS ULCERATIVE 21 0.0005
975 OXYGEN SATURATION DECREASED 26 0.0005
976 RENAL CANCER 22 0.0005
977 PSORIASIS 58 0.0004
978 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
979 CHRONIC KIDNEY DISEASE 33 0.0004
980 ACUTE KIDNEY INJURY 64 0.0004
981 OVERDOSE 90 0.0004
982 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
983 DRUG WITHDRAWAL SYNDROME 35 0.0004
984 PRODUCT QUALITY ISSUE 53 0.0004
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 77 0.0004
986 PLEURAL EFFUSION 22 0.0004
987 NEUTROPENIA 45 0.0003
988 INTENTIONAL OVERDOSE 21 0.0003
989 THROMBOCYTOPENIA 33 0.0003
990 RHEUMATOID ARTHRITIS 28 0.0002
991 TOXICITY TO VARIOUS AGENTS 35 0.0002
992 DRUG DEPENDENCE 17 0.0001